Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trial

  • Joanne V. Glinsky
  • , Jackie Chu
  • , Christine Rimmer
  • , Sharon Roberts
  • , Giorgio Scivoletto
  • , Federica Tamburella
  • , Claire Lincoln
  • , Marsha Ben
  • , Qiang Li
  • , Robert D. Herbert
  • , Fernanda Di Natal
  • , Lydia W. Chen
  • , Donna Rainey
  • , Vivien Jørgensen
  • , Janneke M. Stolwijk
  • , Jessica van der Lede
  • , Charlotte C.M. van Laake-Geelen
  • , Mark McDonald
  • , Emilie J. Gollan
  • , Sue Paddison
  • Chris Bell, Kristine Oostra, Lot Van Roey, Jayanthi Mysore, Annemie I. Spooren, Keira E. Tranter, Hueiming Liu, Stephen Jan, Daniel Treacy, Ian D. Cameron, Gerard Weber, Catherine Sherrington, Euan McCaughey, Emma Leigh Synnott, Jasbeer Kaur, Sachin Shetty, Lisa A. Harvey*
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

BACKGROUND: It is widely believed that intensive task-specific training enhances neurological recovery in people with spinal cord injury (SCI) by exploiting activity-dependent spinal plasticity. We aimed to determine whether 10 weeks of intensive task-specific training supplemented with strength training that targets motor function at and below the level of the lesion improves recovery following recent SCI. METHODS: We conducted a pragmatic phase 3 superiority randomised controlled trial at 15 hospitals in Australia, Belgium, Italy, the Netherlands, Norway, and the UK (England and Scotland). People who sustained a SCI in the preceding 10 weeks, had some motor function below the level of injury, and were receiving inpatient rehabilitation were randomly assigned to usual care (control group) or usual care plus 12 h per week for 10 weeks of intensive task-specific training targeting voluntary motor function below the level of the lesion supplemented with strength training (intervention group). Randomisation was computer generated, concealed, and stratified by site and level of injury. The primary outcome was Total Motor Score of the International Standards for the Neurological Classification of SCI (0-100 points) at 10 weeks. The outcome assessors were blinded to group assignment. Serious adverse events were defined as those resulting in death, life-threatening conditions, prolongation of hospitalisation, or substantial disability. All analyses were conducted by intention to treat. The trial is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12621000091808; universal trial number: U1111-1264-1689). FINDINGS: Between June 7, 2021, and Feb 5, 2025, 220 participants were randomly assigned to the control (n=111; 23 female and 88 male) or intervention (n=109; 28 female and 81 male) group. Data were available for 216 (98%) of 220 participants at 10 weeks (107 in the intervention group and 109 in the control group). The mean Total Motor Scores at 10 weeks were 78·76 (SD 17·34) for the control group and 78·36 (SD 17·00) for the intervention group. The mean between-group difference was 0·93 (95% CI -1·63 to 3·48; p=0·48). There were four serious adverse events (three in the intervention group and one in the control group) including two deaths in participants from the intervention group. INTERPRETATION: Intensive task-specific training supplemented with strength training provided in people with recent SCI did not result in significant benefits on our primary and secondary clinical outcomes. The evidence does not support any beneficial effect of additional training for those receiving usual inpatient rehabilitation care from a multi-disciplinary team. FUNDING: New South Wales Ministry of Health, University of Sydney, and Wings for Life.

Original languageEnglish
Pages (from-to)234-244
Number of pages11
JournalThe Lancet. Neurology
Volume25
Issue number3
DOIs
Publication statusPublished - 1 Mar 2026

Fingerprint

Dive into the research topics of 'Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trial'. Together they form a unique fingerprint.

Cite this